55% of hospitals earn payment bump through value-based purchasing

Just 55 percent of hospitals will earn a payment increase under the Medicare value-based purchasing program in 2019, according to CMS.

The VBP program, which will be in its seventh year in 2019, pays hospitals under the Inpatient Prospective Payment System based on quality of care evaluated against their peers. Hospitals can see adjustments, both positive and negative, in their payments based on quality measurements. In 2019, the total amount available for value-based incentive payments is $1.9 billion.

Out of approximately 2,800 hospitals across the country in the hospital VBP program, more than 1,550 will receive higher Medicare payments, CMS announced. The average net payment adjustment is small, at just 0.17 percent, and nearly 60 percent of hospitals will see a small change in their payment between -0.5 percent and 0.5 percent.

The highest performing hospitals will see a net increase in payments of 3.67 percent in 2019, while the lowest performing hospitals will see a decrease of 1.59 percent. A 2 percent reduction is used as a base operating diagnosis-related group payment amount, and the program is budget neutral.

The average total performance score improved in 2019, up to 38.1 percent, compared to 37.4 percent in 2018.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

California-based Acutus Medical has said its ongoing agreement to manufacture and distribute left-heart access devices for Medtronic is the company's only source of revenue. 

The scam took place over a period of seven years, resulting in Medicare being billed for more than $70 million in fraudulent claims for unnecessary scans. 

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.